These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of exercise on coronary endothelial function in patients with coronary artery disease. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. N Engl J Med; 2000 Feb 17; 342(7):454-60. PubMed ID: 10675425 [Abstract] [Full Text] [Related]
5. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. N Engl J Med; 1993 Jun 10; 328(23):1659-64. PubMed ID: 8487824 [Abstract] [Full Text] [Related]
6. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D. Z Kardiol; 2003 Jun 10; 92(Suppl 3):III42-7. PubMed ID: 14663601 [Abstract] [Full Text] [Related]
7. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group. Kitabatake A, Sato H, Hori M, Kamada T, Kubori S, Hoki N, Minamino T, Yamada M, Kato T. Clin Ther; 1994 Jun 10; 16(3):416-28. PubMed ID: 7923308 [Abstract] [Full Text] [Related]
8. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Wassmann S, Faul A, Hennen B, Scheller B, Böhm M, Nickenig G. Circ Res; 2003 Oct 31; 93(9):e98-103. PubMed ID: 14551237 [Abstract] [Full Text] [Related]
9. Shear stress-dependent platelet function after LDL cholesterol apheresis. Spieker LE, Ruschitzka F, Badimon JJ, Noll G, Corti R. Thromb Res; 2004 Oct 31; 113(6):395-8. PubMed ID: 15226094 [Abstract] [Full Text] [Related]
10. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE. Am Heart J; 2005 Mar 31; 149(3):473. PubMed ID: 15864218 [Abstract] [Full Text] [Related]
11. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. Zeiher AM, Drexler H, Saurbier B, Just H. J Clin Invest; 1993 Aug 31; 92(2):652-62. PubMed ID: 8349804 [Abstract] [Full Text] [Related]
13. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Ohsuzu F, Ishihara M, Kurita A. Int J Cardiol; 2005 Oct 20; 105(1):58-66. PubMed ID: 16207546 [Abstract] [Full Text] [Related]
14. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. J Clin Invest; 1993 Jan 20; 91(1):29-37. PubMed ID: 8423226 [Abstract] [Full Text] [Related]
15. [The effect of LDL-apheresis on the long-term prognosis of hypercholesterolemic patients with coronary artery bypass grafts: a multicenter study]. Kito Y, Takahashi J, Endo M, Agishi T, Kitamura S, Matsuda H, Fujiwara T, Dohi T, Ito T, Kawashima Y. Kyobu Geka; 1993 May 20; 46(5):399-404. PubMed ID: 8492490 [Abstract] [Full Text] [Related]
16. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients. Baldassarre D, Busnach G, Amato M, Pazzucconi F, Sirtori CR. Nutr Metab Cardiovasc Dis; 1999 Jun 20; 9(3):108-17. PubMed ID: 10464783 [Abstract] [Full Text] [Related]
17. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Circulation; 1997 Jan 07; 95(1):76-82. PubMed ID: 8994420 [Abstract] [Full Text] [Related]
18. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin. Matsumoto T, Takashima H, Ohira N, Tarutani Y, Yasuda Y, Yamane T, Matsuo S, Horie M. J Am Coll Cardiol; 2004 Jul 21; 44(2):451-7. PubMed ID: 15261947 [Abstract] [Full Text] [Related]
19. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy]. Seidel D. Z Kardiol; 2003 Jul 21; 92(Suppl 3):III6-27. PubMed ID: 14663597 [Abstract] [Full Text] [Related]
20. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography. Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D. J Heart Lung Transplant; 2005 Dec 21; 24(12):2022-30. PubMed ID: 16364844 [Abstract] [Full Text] [Related] Page: [Next] [New Search]